Biblio Discovery — Demo Discovery Service

198 hasil

Menampilkan 1–20 · 0,44 detik · RSS

Jurnal

Thalassemia Reports

ISSN 2039-4357 · MDPI AG · 198 artikel di indeks

  1. Artikel Jurnal

    Efficacy of ruxolitinib as inducer of fetal hemoglobin in primary erythroid cultures from sickle cell and beta-thalassemia patients

    Alice Pecoraro; Antonio Troia; Aurelio Maggio dkk.

    Thalassemia Reports, Vol. 9 No. 1 · 2019 · Inggris · DOAJ

    High levels of HbF may ameliorate the clinical course of β-thalassaemia and SCD. Hydroxyurea (HU) is the only HbF inducer approved for the treatment of patients. However not all patients respond to the treatment, for this reason it is noteworthy to identify new HbF inducers. Ruxolitinib is a JAK…

  2. Artikel Jurnal

    Migration: The aftershocks to the provision of healthcare

    Stephan Lobitz

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Migration is the “movement of people to a new area or country in order to find work or better living conditions” (Oxford dictionary). The term “migration” summarizes forced, reluctant and voluntary migration. Voluntary migration is a comparatively constant event. But reluctant and, in particular…

  3. Artikel Jurnal

    Safety and efficacy of drugs: What do I need to know?

    Mahmoud Hadipour Dehshal

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Access to the essential medicines is an important challenge in the developing countries. To have access to the quality and affordable medicines, the pharmaceutical decision makers try different strategies. The production of generic and copy medicines is one of the strategies that if adopted based…

  4. Artikel Jurnal

    Diagnosis of haemoglobinopathies: New scientific advances

    Cornelis L. Harteveld

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    The molecular defects underlying haemoglobinopathies are both deletions and point mutations in the alpha- or beta-globin genes or gene-clusters. To detect point mutations causing alpha- or beta-thalassaemia, direct sequencing is the method of choice to detect the widest spectrum of molecular…

  5. Artikel Jurnal

    TIF conference presentation in detail

    Barrister Abid Waheed Shaikh

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    The factors determining the health behaviours may be seen in various contexts: physical, socio-economic, cultural and political. So the utilization of a health care system, public or private, formal or non-formal, may depend on socio-demographic factors, social structures, level of education…

  6. Artikel Jurnal

    The role of the clinical nurse specialist in haemoglobinopathies

    Bernadette Hylton

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    The role of the Clinical Nurse Specialist (CNS) is an everdeveloping role that is integral in the care of individuals with haemoglobinopathies. Haemoglobinopathies are complex disorders that require specialist knowledge to deliver the very best care. In order to offer the best possible patient…

  7. Artikel Jurnal

    New challenges in diagnosis of haemoglobinopathies: Migration of populations

    John Old; Adele Timbs; Janice McCarthy dkk.

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    The current influx of economic migrants and asylum seekers from countries with a high prevalence of haemoglobinopathies creates new challenges for health care systems and diagnostic laboratories. The migration of carriers introduces new and novel haemoglobinopathy mutations to the diagnostic…

  8. Artikel Jurnal

    Informed choice in a multicultural world

    Mary Petrou

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Knowledge and autonomy are key aspects of informed choice; it is important to define what is important for participants to understand, when accepting or declining screening and for individuals to understand that screening is optional and their own personal choice There are no agreed thresholds or…

  9. Artikel Jurnal

    Renal complications in thalassemia

    Joseph Sleiman; Ali Tarhini; Ali T. Taher

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Thalassemia is a disease with an extensive morbidity profile affecting almost every organ system. Renal involvement, once considered rare, is an underestimated and poorly studied complication that has been on the rise ever since medical advances granted patients longer life spans. Several studies…

  10. Artikel Jurnal

    β globin mutations in Turkish, Northern Iraqi and Albanian patients with β thalassemia major

    Veysel Sabri Hancer; Tunc Fisgin; Murat Buyukdogan dkk.

    Thalassemia Reports, Vol. 8 No. 2 · 2018 · Inggris · DOAJ

    The mutation detection of β thalassemia is absolutely necessary for molecular diagnosis, as well as any genetic epidemiological study. The β globin gene has 3 exons and 2 introns, involved in β-thalassemic pathogenesis. The study aim of the study is to characterize the spectrum of β globin gene…

  11. Artikel Jurnal

    Let’s talk about thal: How communication can improve quality of life

    Laurice M. Levine

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    In many parts of the world, research, improved technology, and better medicine have enabled people with thalassemia to live longer. It is tragic that due to global disparity in healthcare, in areas of the world where thalassemia is most prevalent, the mortality rates are high, and often, patients…

  12. Artikel Jurnal

    Hepatitis C virus treatment advances for thalassaemia patients

    George Papatheodoridis

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Chronic infection with hepatitis C virus (HCV) is a major problem for thalassaemia patients, as blood transfusions before 1990 were associated with a high risk of HCV infection. Given the high prevalence of co-morbidities, thalassaemia patients are at an increased risk for dying from end-stage…

  13. Artikel Jurnal

    Haemoglobinopathies care and cure: Have we reached the end?

    John Porter

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Recent years have seen accelerating advances in the treatment, monitoring and potential cures for haemoglobin disorders, as the interaction between basic science, pharmaceutical research, and practical medicine intensifies. In order to appreciate how close to the end we may have reached, it is…

  14. Artikel Jurnal

    Iron overload and chelation therapy in hemoglobinopathies

    Rayan Bou-Fakhredin; Joseph Elias; Ali T. Taher

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Iron overload (IOL) is highly prevalent among patients with hemoglobinopathies; both transfusion dependent thalassemia (TDT) and non-transfusion dependent thalassemia (NTDT). Whether IOL is secondary to regular transfusions like in TDT, or develops from increased intestinal absorption like in NTDT…

  15. Artikel Jurnal

    Diagnostic strategies in hemoglobinopathy testing, the role of a reference laboratory in the USA

    Jennifer L. Oliveira

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Although commonly assessed in the context of microcytosis or sickling syndrome screening, hemoglobin mutations may not be as readily considered as a cause of other symptoms. These include macrocytosis with or without anemia, chronic or episodic hemolysis, neonatal anemia, erythrocytosis…

  16. Artikel Jurnal

    Optimal blood transfusion therapy in haemoglobinopathies

    John Porter

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    For reasons of time, this short talk will be confined to the optimal frequency, timing, indications and dosing of blood transfusion. Blood transfusion protocols in thalassaemia syndromes are more widely agreed (1) than for sickle disorders but questions still remain about optimal Hb levels, timing…

  17. Artikel Jurnal

    Endocrine complications

    Vincenzo de Sanctis

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    More than five decades ago, thalassemia major (TM) was fatal in the first decade of life. This poor prognosis changed since the survival rates started to increase progressively thanks to the implementation of continuous and significant improvement of diagnostic and therapeutic methods, consisting…

  18. Artikel Jurnal

    Heart disease in patients with haemoglobinopathies

    Dimitrios Farmakis; George Papingiotis

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Hereditary hemoglobin disorders, also termed haemoglobinopathies, include mainly beta -thalasszemia and sickle cell disease and represent the most common monogenic disorders in human. Cardiac complications are still a leading cause of mortality and morbidity in patients with haemoglobinopathy…

  19. Artikel Jurnal

    Investigation of some endogenous antimicrobial peptides in thalassemia

    Arif Mustafa Efendiyev; Gulnara Ibrahim Azizova; Arzu Ramiz Dadashova

    Thalassemia Reports, Vol. 8 No. 2 · 2018 · Inggris · DOAJ

    The aim of this work was a comparative study of the amount of antimicrobial peptides - human neutrophil peptides - defensins (HNP), hepcidin, bactericidal/permeability-increasing protein (BPI), and endotoxin in β-thalassemia. Blood samples of 135 patients with thalassemia were investigated. All…

  20. Artikel Jurnal

    PIGI ZOIS: Pioneering with credibility

    Vasilios Perifanis; Ourania Pantelidou; Nousiou Charikleia dkk.

    Thalassemia Reports, Vol. 8 No. 1 · 2018 · Inggris · DOAJ

    Annual transfusion requirements in Greece exceed 600000 blood units and nearly 20% of them are used for the transfusion of 3.000 patients with Thalassemia. Thalassemia patients need to be transfused properly at the right time and with safe, fresh blood. PIGI ZOIS is a nonprofit organization that…